ATE453389T1 - Bestimmte pharmazeutisch wertvolle substituierte aminoalkyl-heterocyclen - Google Patents
Bestimmte pharmazeutisch wertvolle substituierte aminoalkyl-heterocyclenInfo
- Publication number
- ATE453389T1 ATE453389T1 AT03719457T AT03719457T ATE453389T1 AT E453389 T1 ATE453389 T1 AT E453389T1 AT 03719457 T AT03719457 T AT 03719457T AT 03719457 T AT03719457 T AT 03719457T AT E453389 T1 ATE453389 T1 AT E453389T1
- Authority
- AT
- Austria
- Prior art keywords
- substituted aminoalkyl
- certain pharmaceutically
- pharmaceutically valuable
- heterocycles
- valuable substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36841502P | 2002-03-27 | 2002-03-27 | |
PCT/US2003/009039 WO2003082192A2 (en) | 2002-03-27 | 2003-03-26 | Certain pharmaceutically useful substituted aminoalkyl heterocycles |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE453389T1 true ATE453389T1 (de) | 2010-01-15 |
Family
ID=28675483
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03719457T ATE453389T1 (de) | 2002-03-27 | 2003-03-26 | Bestimmte pharmazeutisch wertvolle substituierte aminoalkyl-heterocyclen |
Country Status (8)
Country | Link |
---|---|
US (1) | US7323494B2 (de) |
EP (1) | EP1490047B1 (de) |
JP (1) | JP2005521705A (de) |
AT (1) | ATE453389T1 (de) |
AU (1) | AU2003223340A1 (de) |
DE (1) | DE60330758D1 (de) |
ES (1) | ES2337037T3 (de) |
WO (1) | WO2003082192A2 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040072868A1 (en) * | 2000-09-18 | 2004-04-15 | Collins Jon Loren | Substitued aminopropoxyaryl derivatives useful as agonists for lxr |
US20050171084A1 (en) * | 2002-03-27 | 2005-08-04 | Cairns William J. | Methods of treatment with lxr modulators |
JP2005521721A (ja) | 2002-03-27 | 2005-07-21 | スミスクライン・ビーチャム・コーポレイション | 酸およびエステル化合物ならびにその使用方法 |
JP4471842B2 (ja) | 2002-03-27 | 2010-06-02 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー | アミド化合物および該化合物を用いる方法 |
EP1575495A4 (de) | 2002-03-27 | 2009-12-02 | Smithkline Beecham Corp | Verbindungen und verfahren |
CA2504878A1 (en) * | 2002-11-06 | 2004-05-27 | Schering Corporation | Cholesterol absorption inhibitors for the treatment of demyelination |
FR2869904B1 (fr) | 2004-05-07 | 2006-07-28 | Fournier S A Sa Lab | Modulateurs des recepteurs lxr |
IL166149A0 (en) * | 2005-01-05 | 2006-01-15 | Hadasit Med Res Service | Use of ezetimibe and amiodarone in protection against beta-amyloid neurotoxicity |
EP2098515B1 (de) | 2006-11-30 | 2012-02-08 | Kowa Company, Ltd. | Substituierte carbinolverbindungen |
US7919509B2 (en) | 2008-02-29 | 2011-04-05 | Kowa Company, Ltd. | 2-oxochromene derivatives |
US7951822B2 (en) | 2008-03-31 | 2011-05-31 | Kowa Company, Ltd. | 1,3-dihydroisobenzofuran derivatives |
US8008306B2 (en) | 2008-04-30 | 2011-08-30 | Kowa Company, Ltd. | Quinoline compounds |
JP5541803B2 (ja) | 2008-05-29 | 2014-07-09 | 興和株式会社 | 環状リンカーを有する置換カルビノール化合物 |
JP5774984B2 (ja) | 2009-04-29 | 2015-09-09 | 興和株式会社 | ヘテロ環リンカーを有するカルビノール化合物 |
RU2013115395A (ru) | 2010-09-07 | 2014-10-20 | СНУ Ар энд ДиБи ФАУНДЕЙШН | Сестертерпеновое соединение и его применение |
AU2018226879B2 (en) | 2017-03-03 | 2023-09-14 | Inspirna, Inc. | Formulations with improved stability |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3889545T2 (de) | 1987-10-20 | 1994-10-13 | Otsuka Pharma Co Ltd | Phenylcarbonsäure-abkömmlinge. |
US20030153541A1 (en) * | 1997-10-31 | 2003-08-14 | Robert Dudley | Novel anticholesterol compositions and method for using same |
US6316503B1 (en) | 1999-03-15 | 2001-11-13 | Tularik Inc. | LXR modulators |
AU2000235960A1 (en) * | 2000-02-14 | 2001-08-27 | Tularik, Inc. | Lxr modulators |
US20040072868A1 (en) * | 2000-09-18 | 2004-04-15 | Collins Jon Loren | Substitued aminopropoxyaryl derivatives useful as agonists for lxr |
US20030229062A1 (en) * | 2001-12-07 | 2003-12-11 | The Regents Of The University Of California | Treatments for age-related macular degeneration (AMD) |
US20030162758A1 (en) * | 2001-12-07 | 2003-08-28 | Schwartz Daniel M. | Treatment for age-related macular degeneration (AMD) |
US7470659B2 (en) * | 2001-12-07 | 2008-12-30 | The Regents Of The University Of California | Methods to increase reverse cholesterol transport in the retinal pigment epithelium (RPE) and Bruch's membrane (BM) |
JP2005521721A (ja) | 2002-03-27 | 2005-07-21 | スミスクライン・ビーチャム・コーポレイション | 酸およびエステル化合物ならびにその使用方法 |
JP4471842B2 (ja) | 2002-03-27 | 2010-06-02 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー | アミド化合物および該化合物を用いる方法 |
EP1575495A4 (de) | 2002-03-27 | 2009-12-02 | Smithkline Beecham Corp | Verbindungen und verfahren |
US20050171084A1 (en) * | 2002-03-27 | 2005-08-04 | Cairns William J. | Methods of treatment with lxr modulators |
US20050036992A1 (en) * | 2002-12-23 | 2005-02-17 | Irm Llc | Novel use of liver X receptor agonists |
GB0230177D0 (en) | 2002-12-24 | 2003-02-05 | Karobio Ab | LXR beta crystal |
US20070099884A1 (en) | 2003-06-06 | 2007-05-03 | Erondu Ngozi E | Combination therapy for the treatment of diabetes |
US20060160834A1 (en) | 2003-06-06 | 2006-07-20 | Fong Tung M | Combination therapy for the treatment of hypertension |
US20060189693A1 (en) | 2003-07-22 | 2006-08-24 | Barone Frank C | Methods of treatment with lxr agonists |
WO2005013946A2 (en) | 2003-07-28 | 2005-02-17 | Glaxo Group Limited | Methods of treatment inflammatory bowel with lxr agonists |
WO2005055998A1 (en) | 2003-12-04 | 2005-06-23 | Smithkline Beecham Corporation | Methods of treatment with lxr agonists |
AR047329A1 (es) * | 2003-12-12 | 2006-01-18 | Wyeth Corp | Derivados de quinolinas para el tratamiento de enfermedades cardiovasculares. composiciones farmaceuticas |
WO2006000577A2 (en) | 2004-06-24 | 2006-01-05 | Galapagos N.V. | Lxr agonists to promote bone homeostasis |
KR101266587B1 (ko) | 2004-07-02 | 2013-05-22 | 상꾜 가부시키가이샤 | 조직 인자 생성 억제제 |
-
2003
- 2003-03-26 WO PCT/US2003/009039 patent/WO2003082192A2/en active Application Filing
- 2003-03-26 US US10/508,822 patent/US7323494B2/en active Active
- 2003-03-26 AU AU2003223340A patent/AU2003223340A1/en not_active Abandoned
- 2003-03-26 ES ES03719457T patent/ES2337037T3/es not_active Expired - Lifetime
- 2003-03-26 DE DE60330758T patent/DE60330758D1/de not_active Expired - Lifetime
- 2003-03-26 AT AT03719457T patent/ATE453389T1/de not_active IP Right Cessation
- 2003-03-26 JP JP2003579735A patent/JP2005521705A/ja active Pending
- 2003-03-26 EP EP03719457A patent/EP1490047B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1490047A2 (de) | 2004-12-29 |
ES2337037T3 (es) | 2010-04-20 |
JP2005521705A (ja) | 2005-07-21 |
WO2003082192A3 (en) | 2003-12-18 |
EP1490047A4 (de) | 2006-01-04 |
DE60330758D1 (de) | 2010-02-11 |
AU2003223340A1 (en) | 2003-10-13 |
AU2003223340A8 (en) | 2003-10-13 |
US7323494B2 (en) | 2008-01-29 |
US20050165045A1 (en) | 2005-07-28 |
WO2003082192A2 (en) | 2003-10-09 |
EP1490047B1 (de) | 2009-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE283253T1 (de) | Substituierte aminopropoxyarylderivate als lxr agonisten | |
WO2003082205A3 (en) | Compounds and methods | |
NO2017022I2 (no) | Obetikolsyre | |
RS51444B (sr) | JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa | |
ATE453389T1 (de) | Bestimmte pharmazeutisch wertvolle substituierte aminoalkyl-heterocyclen | |
ATE297203T1 (de) | Antithrombotische mitteln | |
EA200500814A1 (ru) | Производные пирролопиримидина | |
ATE273305T1 (de) | Thrombin-inhibitoren | |
DE602006011752D1 (de) | Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate | |
ATE440603T1 (de) | 8-hydroxychinolinderivate | |
DE602004008098D1 (de) | Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren | |
NO20020214L (no) | Substituerte oksoazaheterocyklylforbindelser | |
CY1111481T1 (el) | Υποκατεστημενα αρυλοκυκλοπροπυλακεταμιδια ως ενεργοποιητες γλυκοκινασης | |
TW200510441A (en) | Novel compounds | |
NO20032801L (no) | Tiazolderivater for behandling av PPAR-relaterte forstyrrelser | |
DE60130771D1 (de) | Substituierte heterocyclische amide | |
ES2243579T3 (es) | Derivados de pirazolopirideno. | |
WO2005003087A3 (en) | Oxazole derivatives as antibacterial agents | |
NO20025035D0 (no) | Oksadiazolderivater som har anticancer-effekter | |
ID24846A (id) | Turunan-turunan bifenilamidina | |
ATE308540T1 (de) | Antithrombosemittel | |
DK1209151T3 (da) | 4-substituerede piperidinderivativer | |
WO2003093247A3 (en) | Antibacterial agents | |
ATE382607T1 (de) | Antitrombotische aether | |
TW200508211A (en) | 2-naphthylimino-1,3-thiazine derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |